Enanta Pharmaceuticals
ENTA
#8287
Rank
C$0.46 B
Marketcap
C$15.92
Share price
-2.18%
Change (1 day)
-1.39%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -C$70.13 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$65.25 Million. In 2025 the company made an earning of -C$90.74 Million, an increase over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$70.13 Million-22.72%
2025 -C$90.74 Million-34.07%
2024 -C$0.14 Billion-23.87%
2023 -C$0.19 Billion4.39%
2022 -C$0.18 Billion-4.4%
2021 -C$0.19 Billion91.12%
2020 -C$94.79 Million-407.13%
2019 C$30.86 M-78.63%
2018 C$0.14 B117.97%
2017 C$66.26 M-574.65%
2016 -C$13.97 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$25.08 Million-137.98%
2012 C$66 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.56 B-37,381.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$17.93 B-25,277.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$18.18 B-25,618.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$6.47 B-9,183.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.53 B-13,488.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.07 B-22,666.96%๐Ÿ‡บ๐Ÿ‡ธ USA